About Motif

We're building the future of intelligent research assistance, making precision medicine accessible to researchers worldwide through AI agent collaboration.

Our Mission: Making Biomarker Discovery 100x Faster With AI-Powered Cross-Referencing

Every year, millions of patients don't respond to their treatments because we lack the right biomarkers to guide therapy selection. Meanwhile, researchers spend months manually reviewing literature that our AI-powered cross-referencing platform analyzes across 29+ clinical, genomic, and pathway databases in minutes, 100x faster than manual research.

At Motif, we're making the world's biomedical knowledge instantly searchable and research-actionable through multi-agent collaboration with real-time checks across CIViC, DGIdb, PharmGKB, ClinVar, FDA, and 10+ additional research databases for precision medicine.

Our platform combines 9 specialized AI agents that work together to search millions of papers, extract biomarker entities, cross-reference across 29+ databases, build interactive knowledge graphs, and synthesize research findings, all while streaming results in real-time. What takes 6 months manually takes 6 minutes with Motif.

Comprehensive validation

Every biomarker is cross-referenced across 29+ databases spanning clinical (CIViC, DGIdb), genomic (gnomAD), pathway (Reactome), and regulatory (FDA) sources with multi-tier evidence scoring and real-time streaming results

29+

Databases integrated

1M+

Papers analyzed

87%

Prediction accuracy

24/7

Continuous learning

Our Values in AI-Powered Biomedical Research

The principles that guide how we build intelligent agents to accelerate medical research through collaboration.

Scientific Rigor

Every result is validated against research and clinical databases with statistical significance testing and confidence scoring. We never compromise on accuracy.

Global Access

Breakthrough discoveries shouldn't be limited by geography or resources. We make advanced AI accessible to researchers worldwide.

Collaborative Innovation

We design AI agents to work hand-in-hand with researchers, enabling knowledge sharing, cross-disciplinary insights, and collective progress toward medical breakthroughs.

Our Technology: 9 Specialized AI Agents for Cross-Referencing & Discovery

Built on cutting-edge AI architecture designed specifically for collaborative biomedical research assistance.

Multi-Agent AI System

Specialized Agent Team

Many specialized AI agents collaborate on different aspects of biomarker discovery, from literature search to research validation.

Real-Time Collaboration

Streaming results as they're discovered, with intelligent agent coordination and parallel database searches.

Continuous Learning

Our agent team continuously improves from new research, ensuring you always have access to the latest discoveries.

Trusted Data Sources

Integrated access to 29+ scientific databases for comprehensive research validation

  • PubMed biomedical literature databasePubMed
  • PubMed Central full-text archivePubMed Central
  • Europe PubMed Central research databaseEurope PubMed Central
  • CIViC clinical variant interpretation databaseCIViC
  • DGIdb drug-gene interaction databaseDGIdb
  • ClinVar genetic variant databaseClinVar
  • ClinPGx pharmacogenomics databaseClinPGx
  • gnomAD genome aggregation databasegnomAD
  • dbSNP genetic variation databasedbSNP
  • FDA regulatory and drug approval databaseFDA
  • ClinicalTrials.gov clinical studies databaseClinicalTrials.gov
  • Gene Ontology biological process databaseGene Ontology
  • Reactome biological pathway databaseReactome
  • HGNC gene nomenclature databaseHGNC
  • Ensembl genome annotation databaseEnsembl
  • TCGA cancer genomics databaseTCGA
  • Hugging Face AI model repositoryHugging Face

Built for Drug Discovery, Diagnostics & Academic Research

Accelerating biomarker research across pharmaceutical companies, diagnostic developers, and academic institutions

Drug Discovery & Development

Identify and validate therapeutic targets with AI-powered cross-referencing across clinical and genomic databases.

• 6-12 months faster timelines
• Higher trial success rates
• Better patient stratification

Diagnostic Innovation

Surface biomarker candidates for early detection ranked by assay readiness and clinical relevance.

• 75% faster test development
• Earlier disease detection
• Clear competitive landscape

Academic Research

Transform vague research ideas into grant-ready documentation with comprehensive evidence and citations.

• 20+ hours saved per week
• Stronger grant proposals
• Cross-field discoveries

The Motif Advantage

Quantifiable improvements over manual biomarker research

100x
Faster than manual methods

Literature review speed

29+
Databases cross-referenced

Clinical, genomic, pathway, regulatory

9
Specialized AI agents

Working in parallel collaboration

6 min*
Average completion

From query to comprehensive results

*Processing time may vary depending on query complexity and configurations.

Explore our AI biomarker discovery features or read the latest insights on biomedical research and AI.

Ready to accelerate your research?

Join our waitlist to get early access to the most advanced AI research assistant powered by intelligent agent collaboration.